EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy of 18 FDG‐PET/CT in Detecting Synchronous Malignancies in Patients With Head and Neck Cancer: A Systematic Review and Meta‐analysis

Soroush Ershadifar, Jordan Larsson iD, Kurtis Young iD, Marianne Abouyared iD, Arnaud Bewley iD, Andrew C Birkeland iD

Otolaryngology–Head and Neck Surgery · 2024-12 · 171 (6) · 1639-1649

DOI: 10.1002/ohn.879 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 29.06.2024. Verfasst von Soroush Ershadifar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California-Davis, Sacramento, California, USA. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Head and Neck Neoplasms, Radiopharmaceuticals. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the diagnostic accuracy of fluorine‐18 fluorodeoxyglucose positron emission tomography and computed tomography ( 18 FDG‐PET/CT) in detecting second primary malignancies (SPMs) in patients with treatment naïve head and neck squamous cell carcinoma (HNSCC). Data Sources Medline, Embase, Cochrane Library, and Scopus searched from 1946 to December 2022. Review Methods Studies reporting the performance of 18 FDG‐PET/CT in patients with treatment‐naïve, index HNSCC for detection of SPMs were included. The reference standard was histopathology, clinical follow‐up over the duration of study, and other imaging modalities. Multiple investigators completed depth full‐text analysis. Preferred Reporting Items for Systematic Reviews and Meta‐analysis guidelines were followed. Methodologic and diagnostic accuracy data were abstracted independently by multiple investigators. Risk of bias assessment was conducted using the Quality Assessment of Diagnostic Accuracy Studies tool independently. Bivariate random‐effects model meta‐analysis and multivariable meta‐regression modeling were used.

Results

Seventeen studies examining 4624 patients with a total of 475 SPMs were included in the final analysis. Eleven studies were found to be at low risk for bias, while the rest were in the high‐risk category. 18 FDG‐PET/CT demonstrated pooled sensitivity and specificity of 0.73 (95% confidence interval [CI]: 0.49‐0.88) and 0.99 (95% CI: 0.98‐1.00) in detecting SPMs. Further subsite analysis revealed varied diagnostic performance across different anatomical regions, with sensitivity and specificity of esophageal SPMs being 0.47 (0.30‐0.64) and 0.99 (0.98‐1.00), and sensitivity and specificity of 0.86 (0.73‐0.94) and 0.99 (0.98‐1.00) for head and neck SPMs. Finally, this imaging modality showed sensitivity and specificity of 0.92 (0.84‐0.96) and 0.99 (0.98‐1.00) for lung SPMs.

Conclusion

The findings of this study suggest varied accuracy of 18 FDG‐PET/CT in detecting SPMs during initial workup for HNSCC, highlighting the importance of screening modalities such as esophagoscopy in high‐risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyHead and Neck NeoplasmsRadiopharmaceuticalsNeoplasms, Multiple PrimaryHumansSquamous Cell Carcinoma of Head and NeckSensitivity and SpecificityNeoplasms, Second Primary

Stichwörter der Autor:innen

diagnostic imaginghead and neck cancersecond primary malignancies

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of California-Davis, Sacramento, California, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Nevada-Las Vegas, Las Vegas, Nevada, USA.

ORCID-Profile: Jordan Larsson, Kurtis Young, Marianne Abouyared, Arnaud Bewley, Andrew C Birkeland

Zitieren

APA

Ershadifar, S., Larsson, J., Young, K., Abouyared, M., Bewley, A., & Birkeland, A. C. (2024). Efficacy of 18 FDG‐PET/CT in Detecting Synchronous Malignancies in Patients With Head and Neck Cancer: A Systematic Review and Meta‐analysis. Otolaryngology–Head and Neck Surgery, 171(6), 1639-1649. https://doi.org/10.1002/ohn.879

Vancouver

Ershadifar S, Larsson J, Young K, Abouyared M, Bewley A, Birkeland AC. Efficacy of 18 FDG‐PET/CT in Detecting Synchronous Malignancies in Patients With Head and Neck Cancer: A Systematic Review and Meta‐analysis. Otolaryngology–Head and Neck Surgery. 2024;171(6):1639-1649. doi:10.1002/ohn.879

BibTeX
@article{Ershadifar2024,
  author = {Ershadifar, Soroush and Larsson, Jordan and Young, Kurtis and Abouyared, Marianne and Bewley, Arnaud and Birkeland, Andrew C},
  title = {Efficacy of 18 FDG‐PET/CT in Detecting Synchronous Malignancies in Patients With Head and Neck Cancer: A Systematic Review and Meta‐analysis},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  volume = {171},
  number = {6},
  pages = {1639--1649},
  doi = {10.1002/ohn.879}
}
Kostenlos starten →